A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma

Figure 4

Predictive performance of the signature. (a) and (d) Survival analysis in the TCGA and the GEO datasets. (b) and (e) ROC curves of the signature. (c) and (f) The risk distribution plots in two independent cohorts.

(a)

(b)

(c)

(d)

(e)

(f)